Pelvic Congestion Syndrome Following Salpingectomy Compared to Tubal Ligation at Time of Caesarean Section

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Permanent tubal sterilization during Caesarean section is a reliable method of contraception. It is done either by bilateral tubal ligation or bilateral salpingectomy according to surgeon's preference. Studies revealing bilateral salpingectomy has an added benefit of primary prevention of ovarian cancer has encouraged surgeons to perform bilateral salpingectomy rather than tubal ligation as a risk reducing surgery owing to the acceptance of fallopian tubes as the origin of high grade serous ovarian cancer. Another aspect to take into consideration is the post tubal ligation syndrome as it severely affects the quality of life. Diagnosis is based on clinical picture, imaging, and exclusion of other causes of chronic pelvic pain. Women experience dysmenorrhea, dyspareunia, menstrual irregularities, and pelvic pain. The gold standard is venography; however, the first choice for initial evaluation is duplex ultrasound. In this study, we assess impact of bilateral salpingectomy versus tubal ligation in terms of pelvic congestion by participant's symptoms and ultrasound findings

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 30
Healthy Volunteers: t
View:

• Females undergoing caesarean section and requesting tubal sterilization as a permanent method of contraception.

• 30 years or older

Locations
Other Locations
Egypt
Ain Shams Maternity Hospitals
RECRUITING
Cairo
Contact Information
Primary
Mayar Z Kamal
mayarziad2@gmail.com
Time Frame
Start Date: 2024-05-21
Estimated Completion Date: 2024-09
Participants
Target number of participants: 64
Treatments
Active_comparator: Participants undergoing caesarean section and salpingectomy.
Active_comparator: Participants undergoing caesarean section and tubal ligation
Sponsors
Leads: Ain Shams University

This content was sourced from clinicaltrials.gov